Adimab, LLC

United States of America


 
Total IP 144
Total IP Rank # 9,153
IP Activity Score 2.9/5.0    100
IP Activity Rank # 6,943
Dominant Nice Class Chemical and biological material...

Patents

Trademarks

60 8
24 2
46 4
0
 
Last Patent 2025 - Il-18 polypeptides and uses thereof
First Patent 2000 - High throughput generation and s...
Last Trademark 2014 - ADIMAB
First Trademark 2007 - ADIMAB

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 Invention Il-18 polypeptides and uses thereof. Provided herein are IL- 18 polypeptide variants that have bi...
Invention Inducible il-18 prodrugs. Provided herein are IL- 18 polypeptide prodrugs comprising IL- 18, a ha...
Invention Anti-cd28 antibodies and methods related thereto. inter aliavivo vivo methods, and manufacturing ...
Invention Antibody libraries. The present invention overcomes the inadequacies inherent in the known metho...
Invention Antibodies against orthohantaviruses. Provided herein are hantivirus antibodies. These hantivirus...
2023 Invention Anti-activin a/b antibodies and uses thereof. Provided herein are antibody agents that bind speci...
Invention Ph-dependent anti-cd3 antibodies and methods relating thereto. vivo vivo methods, screening metho...
Invention Rationally designed, synthetic antibody libraries and uses therefor. The present invention overc...
Invention Anti-coagulation factor xi antibodies. Antibodies that bind the apple 3 domain of human coagulati...
Invention Myeloproliferative conditions. Provided herein are antibody agents that bind specifically to Act...
Invention Myeloproliferative conditions. Provided herein are antibody agents that bind specifically to Acti...
2022 Invention Targeting gdf15-gfral pathway. Provided herein are methods of treating and/or preventing certain ...
Invention Anti-idiotype antibodies. The present disclosure relates to anti-idiotypic antibodies binding to...
Invention Anti-idiotype antibodies. The present disclosure relates to anti-idiotypic antibodies binding to ...
Invention Anti-cd3-binding domains and antibodies comprising them, and methods for their generation and use...
Invention Systems and methods for intelligent construction of antibody libraries. Presented herein are sys...
Invention Systems and methods for intelligent construction of antibody libraries. Presented herein are syst...
Invention Anti-activin a antibodies, compositions and uses thereof. Provided herein are antibody agents tha...
Invention Anti-cd3 antibodies. The present disclosure includes anti-CD3 binding domains and antibodies and...
Invention Anti-cd3 antibodies. The present disclosure includes anti-CD3 binding domains and antibodies and/...
Invention Anti-respiratory syncytial virus antibodies, and methods of their generation and use. Anti-RSV an...
Invention Anti-gdf15 antibodies, compositions and uses thereof. Provided herein are antibody agents that b...
Invention Anti-gdf15 antibodies, compositions and uses thereof. Provided herein are antibody agents that bi...
Invention Monoclonal antibodies and cocktails for treatment of ebola infections. Described herein are compo...
Invention Fc variants with reduced effector function. The present invention provides Fc variants and polyp...
Invention Polyclonal mixtures of antibodies, and methods of making and using them. A method of broadening e...
Invention Ltbp complex-specific inhibitors of tgfβ and uses thereof. Disclosed herein are inhibitors, such ...
Invention Variant ch3 domains engineered for preferential ch3 heterodimerization, multi-specific antibodies...
Invention Variant ch1 domains and variant cl domains engineered for preferential chain pairing and multi-sp...
2021 Invention Anti-crimean-congo hemorrhagic fever virus antibodies, and methods of their generation and use. ...
2020 Invention Antibodies against bace1 and use thereof for neural disease immunotherapy. The invention provides...
Invention Polyspecificity reagents, methods for their preparation and use. The present invention relates, i...
Invention Antibody libraries. The present invention overcomes the inadequacies inherent in the known method...
Invention Ch1 domain variants engineered for preferential light chain pairing and multispecific antibodies ...
Invention High affinity anti-cd3 antibodies, and methods for their generation and use. Antibodies and anti...
Invention Engineered ph-dependent anti-cd3 antibodies, and methods for their generation and use. Engineere...
2014 G/S Antibodies for commercial use, namely, for medical diagnostic and therapeutic use; biochemicals i...
G/S Antibodies for commercial use, namely, for medical diagnostic and therapeutic use; antibodies for...
2011 G/S Antibodies for commercial use, namely, for industrial, scientific or research use. Antibodies fo...
2008 G/S Biochemical preparations, namely antibodies for commercial use, specifically for industrial, sci...
2007 G/S Antibodies for commercial use, namely, for industrial, scientific or research use
G/S Scientific research and development, namely, development of antibodies for others
G/S Custom antibody production and generation; custom manufacture of antibodies for others
G/S Antibodies for commercial use, namely, for medical diagnostic and therapeutic use